Malegra 50 mg contains sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). Prescribing decisions should follow established sildenafil guidelines and consider the patient's medical history, cardiovascular health, and current medications.

1. Initial Assessment

A clinician should assess the duration and severity of ED, possible underlying causes, blood pressure, cardiovascular risk factors, and current medications. Persistent ED may warrant evaluation for diabetes or other health conditions.

2. Recommended Dosage

For most adults, Malegra 50 mg is a standard starting dose taken as needed, approximately one hour before sexual activity. Depending on effectiveness and tolerability, a clinician may adjust the dose to 25 mg or up to 100 mg. The maximum recommended frequency is once daily.

3. Contraindications and Precautions

Sildenafil must not be combined with nitrate medicines or riociguat because of the risk of dangerously low blood pressure. Caution is also necessary with alpha-blockers, certain interacting medicines, and significant cardiovascular disease.

4. Monitoring and Follow-Up

Follow-up should assess treatment effectiveness, adverse effects, and whether the underlying cause of ED requires additional treatment. Common side effects include headache, flushing, and indigestion.

Malegra 50 mg may be appropriate for some men with ED when prescribed following an individual assessment. Because brand quality and formulation can vary, verify the product with a pharmacist and use it under qualified medical supervision.